Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117548279 | 11754827 | 9 | F | 20160827 | 20151119 | 20160908 | EXP | US-ELI_LILLY_AND_COMPANY-US201511003324 | ELI LILLY AND CO | 0.00 | M | Y | 126.80000 | KG | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117548279 | 11754827 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Unknown | 15MG, EACH EVENING | 20592 | 15 | MG | QD | |||||||
| 117548279 | 11754827 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | 5 MG, UNKNOWN | 20592 | 5 | MG | ||||||||
| 117548279 | 11754827 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | 10 MG, QD | 20592 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117548279 | 11754827 | 1 | Psychotic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117548279 | 11754827 | HO |
| 117548279 | 11754827 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117548279 | 11754827 | Abdominal pain upper | |
| 117548279 | 11754827 | Alopecia | |
| 117548279 | 11754827 | Bipolar I disorder | |
| 117548279 | 11754827 | Blood cholesterol increased | |
| 117548279 | 11754827 | Constipation | |
| 117548279 | 11754827 | Diabetes mellitus | |
| 117548279 | 11754827 | Dizziness | |
| 117548279 | 11754827 | Dry mouth | |
| 117548279 | 11754827 | Dyspepsia | |
| 117548279 | 11754827 | Fatigue | |
| 117548279 | 11754827 | Headache | |
| 117548279 | 11754827 | Hypersomnia | |
| 117548279 | 11754827 | Hypertension | |
| 117548279 | 11754827 | Hypoaesthesia | |
| 117548279 | 11754827 | Increased appetite | |
| 117548279 | 11754827 | Intervertebral disc space narrowing | |
| 117548279 | 11754827 | Memory impairment | |
| 117548279 | 11754827 | Onychophagia | |
| 117548279 | 11754827 | Pain in extremity | |
| 117548279 | 11754827 | Panic attack | |
| 117548279 | 11754827 | Paraesthesia | |
| 117548279 | 11754827 | Psychotic disorder | |
| 117548279 | 11754827 | Restlessness | |
| 117548279 | 11754827 | Sleep apnoea syndrome | |
| 117548279 | 11754827 | Somnolence | |
| 117548279 | 11754827 | Spinal osteoarthritis | |
| 117548279 | 11754827 | Stress | |
| 117548279 | 11754827 | Suicide attempt | |
| 117548279 | 11754827 | Treatment noncompliance | |
| 117548279 | 11754827 | Urinary incontinence | |
| 117548279 | 11754827 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117548279 | 11754827 | 1 | 201101 | 0 |